Navigation Links
Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS)

mpact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry, the difficulty of predicting U.S. Food and Drug Administration, European Medicines Agency and other regulatory authority approvals, the regulatory environment and changes in the health policies and structures of various countries, our ability to achieve expected results though our innovative R&D efforts, Teva's ability to successfully identify, consummate and integrate acquisitions, potential exposure to product liability claims to the extent not covered by insurance, dependence on the effectiveness of our patents and other protections for innovative products, significant operations worldwide that may be adversely affected by terrorism, political or economical instability or major hostilities, supply interruptions or delays that could result from the complex manufacturing of our products and our global supply chain, environmental risks, fluctuations in currency, exchange and interest rates, and other factors that are discussed in Teva's Annual Report on Form 20-F and its other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Contact

Teva:
Teva Pharmaceutical Industries Ltd.
Dan Suesskind, Chief Financial Officer
+ 972 2 589 28 40
or
Teva North America
George Barrett, President and CEO
+1 215 591 30 30
or
Teva Investor Relations
Liraz Kalif / Kevin Mannix
+972 3 926 72 81 / +1 215 591 89 12
or
Active Biotech:
Sven Andréasson, President & CEO
+46 46 19 20 49
Tomas Leander
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
2. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
3. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
4. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
5. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
6. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
7. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
8. Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory Compound, Shows Efficacy in Psoriasis
9. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
10. Encouraging Clinical Activity of GSKs Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
11. Clinical Data on ARIADs Novel mTOR Inhibitor, AP23573, To Be Presented at the ASCO Annual Meeting
Post Your Comments:
(Date:10/27/2014)... , Oct. 27, 2014  RenovoRx, a leading ... flow and delivery of fluids to selected sites in ... of Directors has appointed Shaun Bagai as ... the RenovoRx Board of Directors. Bagai brings more than ... Bagai joined RenovoRx in June 2014 and ...
(Date:10/27/2014)... , Oct. 27, 2014  In the last few weeks, ... Africa to a worldwide crisis when a ... the virus and died, and two nurses were infected. ... could happen, the use of modern technology, such as electronic health ... unnoticed. This week, InformationWeek Healthcare Editor Alison Diana ...
(Date:10/27/2014)... Research and Markets has announced ... 2014-2018" report to their offering. ... a variety of tasks that might be simple or ... into two broad divisions: Professional Robot and Personal/domestic Robot. ... challenging environment such as underwater applications, defense, and security ...
Breaking Medicine Technology:RenovoRx Board Names Shaun R. Bagai as CEO 2EHRs in the Age of Ebola: Discuss on InformationWeek 2EHRs in the Age of Ebola: Discuss on InformationWeek 3Global Service Robot Market 2014-2018: Key Vendors are GeckoSystem, Honda Motor, iRobot and Toyota Motor 2Global Service Robot Market 2014-2018: Key Vendors are GeckoSystem, Honda Motor, iRobot and Toyota Motor 3
(Date:10/30/2014)... (PRWEB) October 30, 2014 Nutrition Leaders, ... supplements, weight loss aids, and more, is currently hosting ... which is already underway, is open to U.S. residents ... on December 15, 2014. One lucky winner will then ... receive a $100 gift card to NutritionLeaders.com. , Nutrition ...
(Date:10/30/2014)... 2014 Don Allred Insurance, a leading ... plans for North Carolina residents, is excited to announce ... Holly Hill Mall. The new branch has been up ... customers through all facets of the insurance selection process ... spokesman Scott Allred couldn’t be happier with the timing ...
(Date:10/30/2014)... 2014 PreDiabetes Centers , the ... shoppers with a supply of sugardown®, a chewable ... post-meal blood sugar spikes. Learning how to control blood ... part of a diabetes prevention plan. , Shoppers who ... complimentary tube of sugardown. The offer expires November 30. ...
(Date:10/30/2014)... Steven Reinberg HealthDay Reporter ... therapy to men with prostate cancer who also have certain ... heart-related cause, a new study suggests. , , The therapy in ... prostate cancer to reduce levels of male hormones to prevent ... in the current research, this hormone therapy was linked to ...
(Date:10/30/2014)... Home Care Assistance – Halton/Peel Region ... in-home senior care, is weighing in on a recent ... The study, performed by the University of Illinois, analyzed ... over a week-long period and observed how much time ... By examining the structural soundness of the white matter ...
Breaking Medicine News(10 mins):Health News:Nutrition Leaders Announces Gift Card Sweepstakes 2Health News:Allred Insurance Satellite Office Grand Opening 2Health News:PreDiabetes Treatment Company Offers PreD Store Shoppers Supplements to Support Healthy Blood Sugar 2Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 2Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3
... emotional toll on unemployed, families, even those still working, , , ... more bad news on the U.S. economic crisis, the monetary ... to measure than the mental toll on the thousands of ... you lose a job, the losses are multiple," explained Michael ...
... Publishes Letter Outlining Strategy, Market Opportunity and New ... Inc. (OTC Bulletin Board: MCLN), a provider of ... and disposal of regulated medical waste, today announced ... published a letter to shareholders. The letter, ...
... All-Star Chris Paul and WNBA,All-Star Diana Taurasi, are teaming ... a new national campaign called Get Fit By Finals. ... All-Star 2009 in Phoenix, Ariz., is,part of a new ... and,NBA FIT, the NBA,s comprehensive health and wellness initiative ...
... Observance To Draw Attention To "The Sneak Thief of Sight" ... effort to combat one of the leading causes of blindness ... Organization have set March 12, 2009, as the second ... by awareness and educational events organized by eye care institutions ...
... brings extensive experience in neuroscience and oncology to ... therapeutic categories , , ROCKVILLE, Md. ... Pharmaceutical, Inc. (OAPI), a fast-growing health care company ... North America, has announced the appointment of Mark ...
... ROCKVILLE, Md., Feb. 12 Neuralstem, Inc. (NYSE ... former Senator (D-Tennessee) and former Ambassador to the ... Advisory Board and will serve as senior advisor ... was elected to the United States Senate from ...
Cached Medicine News:Health News:Job Losses Carry High 'Stress Tag' 2Health News:Job Losses Carry High 'Stress Tag' 3Health News:Job Losses Carry High 'Stress Tag' 4Health News:MedClean Technologies Inc. CEO Publishes Letter to Shareholders 2Health News:The NBA Teams up With Body By Milk to Challenge Teenagers to 'Get Fit By Finals' 2Health News:The NBA Teams up With Body By Milk to Challenge Teenagers to 'Get Fit By Finals' 3Health News:The NBA Teams up With Body By Milk to Challenge Teenagers to 'Get Fit By Finals' 4Health News:The NBA Teams up With Body By Milk to Challenge Teenagers to 'Get Fit By Finals' 5Health News:World Glaucoma Day Set For March 12, 2009 2Health News:World Glaucoma Day Set For March 12, 2009 3Health News:World Glaucoma Day Set For March 12, 2009 4Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 2Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 3Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 4Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 5Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 6Health News:Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board 2Health News:Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board 3
... Microvolume technology , The ADVIA 1650 has ... as 2 L/test), reagent consumption (as low ... L/hour) - thus maximizing management efficiency. , ... cycle and system throughput of up to ...
... and controls interchangeable with other Roche/Hitachi ... training costs. Consistent patient results throughout ... handling. 70 positions for routine, STAT ... volumes. Intermix sample types. Intermix 5 ...
With the sample processing core unit and intelligent process management, combines a wide variety of analytical modules to enable full consolidation of clinical chemistry and immunochemistry....
... The Roche Diagnostics Task ... a state-of-the-art automation of ... the laboratories: decapping, sorting / ... aliquoting into bar code labeled ...
Medicine Products: